These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inhibiting PGGT1B Disrupts Function of RHOA, Resulting in T-cell Expression of Integrin α4β7 and Development of Colitis in Mice. López-Posadas R; Fastancz P; Martínez-Sánchez LDC; Panteleev-Ivlev J; Thonn V; Kisseleva T; Becker LS; Schulz-Kuhnt A; Zundler S; Wirtz S; Atreya R; Carlé B; Friedrich O; Schürmann S; Waldner MJ; Neufert C; Brakebusch CH; Bergö MO; Neurath MF; Atreya I Gastroenterology; 2019 Nov; 157(5):1293-1309. PubMed ID: 31302143 [TBL] [Abstract][Full Text] [Related]
4. A mutation that blocks integrin α Zhang H; Zheng Y; Pan Y; Lin C; Wang S; Yan Z; Lu L; Ge G; Li J; Zeng YA; Chen J BMC Biol; 2020 Jun; 18(1):64. PubMed ID: 32522281 [TBL] [Abstract][Full Text] [Related]
5. Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice. Maggio-Price L; Shows D; Waggie K; Burich A; Zeng W; Escobar S; Morrissey P; Viney JL Am J Pathol; 2002 Feb; 160(2):739-51. PubMed ID: 11839595 [TBL] [Abstract][Full Text] [Related]
6. The Underappreciated Role of Secretory IgA in IBD. Bamias G; Kitsou K; Rivera-Nieves J Inflamm Bowel Dis; 2023 Aug; 29(8):1327-1341. PubMed ID: 36943800 [TBL] [Abstract][Full Text] [Related]
7. Association of Vedolizumab Level, Anti-Drug Antibodies, and α4β7 Occupancy With Response in Patients With Inflammatory Bowel Diseases. Ungar B; Kopylov U; Yavzori M; Fudim E; Picard O; Lahat A; Coscas D; Waterman M; Haj-Natour O; Orbach-Zingboim N; Mao R; Chen M; Chowers Y; Eliakim R; Ben-Horin S Clin Gastroenterol Hepatol; 2018 May; 16(5):697-705.e7. PubMed ID: 29223444 [TBL] [Abstract][Full Text] [Related]
8. Non-classical monocyte homing to the gut via α4β7 integrin mediates macrophage-dependent intestinal wound healing. Schleier L; Wiendl M; Heidbreder K; Binder MT; Atreya R; Rath T; Becker E; Schulz-Kuhnt A; Stahl A; Schulze LL; Ullrich K; Merz SF; Bornemann L; Gunzer M; Watson AJM; Neufert C; Atreya I; Neurath MF; Zundler S Gut; 2020 Feb; 69(2):252-263. PubMed ID: 31092589 [TBL] [Abstract][Full Text] [Related]
9. Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis. Han B; Lv X; Liu G; Li S; Fan J; Chen L; Huang Z; Lin G; Xu X; Huang Z; Zhan L; Lv X Gut Microbes; 2023; 15(1):2232143. PubMed ID: 37431863 [TBL] [Abstract][Full Text] [Related]